3
Most read
9
Most read
11
Most read
Mohammad saleh Moallem
SHANDONG UNIVERSITY
 What is the neostigmine? Please talk about
its medical uses, mechanism of action and
side effects.
Question
Neostigmine Neostigmine is a medication used to treat
myasthenia gravis, Ogilvie syndrome, and
urinary retention without the presence of a
blockage.
It is also used in Anaesthesia to end the effects
of non-depolarizing neuromuscular blocking
medication. It is given by injection either into a
vein, muscle, or under the skin. After injection
effects are generally greatest within 30
minutes and last up to 4 hours.
Indications of Neostigmine
Myasthenia gravis (MG) is a chronic
autoimmune disorder in which antibodies
destroy the communication between nerves
and muscle, resulting in weakness of the
skeletal muscles.
Myasthenia gravis affects the voluntary
muscles of the body, especially those that
control the eyes, mouth, throat and limbs.
Indications of Neostigmine
Ogilvie syndrome is the acute dilatation
of the colon in the absence of any
mechanical obstruction in severely ill
patients. Ogilvie syndrome may occur
after surgery, especially following
coronary artery bypass surgery and
total joint replacement.
Drugs that disturb colonic motility (such as anticholinergics or opioid analgesics)
contribute to the development of this condition.
Neostigmine Neostigmine is a cholinesterase inhibitor used
in the symptomatic treatment of myasthenia
gravis by improving muscle tone.
Cholinesterase is a family of enzymes that
catalyzes the hydrolysis of the neurotransmitter
acetylcholine (ACh) into choline and acetic
acid, a reaction necessary to allow a
cholinergic neuron to return to its resting state
after activation. So cholinesterase decrease
the amount of Ach
Description
Acetylcholine is the chief neurotransmitter of the
parasympathetic nervous system, the part of the
autonomic nervous system (a branch of PNS) that
contracts smooth muscles, dilates blood vessels,
increases bodily secretions, and slows heart rate.
In most people with myasthenia gravis, the immune
system blocks or damages these acetylcholine receptors.
The acetylcholine cannot then attach to the receptor and
so the muscle is less able to contract.
Description
Cholinergic drugs stimulate the activation of
the parasympathetic nervous system by
activating receptors for acetylcholine.
Anticholinergic drugs inhibit the
parasympathetic nervous system by blocking
the action of acetylcholine so that it cannot
bind to receptors that initiate the
parasympathetic response.
Neostigmine Neostigmine is a cholinesterase inhibitor used
in the symptomatic treatment of myasthenia
gravis by improving muscle tone.
Neostigmine is in the cholinergic family of
medications. It works by blocking the action of
acetylcholinesterase and therefore increases
the levels of acetylcholine.
Neostigmine: Cholinesterase inhibitor = ↑ ACh
Neostigmine Neostigmine: Cholinesterase inhibitor = ↑ Ach
Neostigmine works by slowing the breakdown
of acetylcholine when it is released from nerve
endings. This means that there is more
acetylcholine available to attach to the muscle
receptors and this improves the strength of
your muscles.
Neostigmine, unlike physostigmine, does not
cross the blood-brain barrier.
Neostigmine Neostigmine is a parasympathomimetic, specifically,
a reversible cholinesterase inhibitor. The drug inhibits
acetylcholinesterase which is responsible for the
degradation of acetylcholine.
So, with acetylcholinesterase inhibited, more
acetylcholine is present By interfering with the
breakdown of acetylcholine, neostigmine indirectly
stimulates both nicotinic and muscarinic receptors
which are involved in muscle contraction. It does not
cross the blood-brain barrier.
How it acts as anticholinesterase?
Neostigmine is an anticholinesterase inhibitor and
inhibits the hydrolysis of acetylcholine by competing
with acetylcholine for binding to acetylcholinesterase
at the site of cholinergic transmission. By reducing the
hydrolysis of acetylcholine, the transmission of nerve
impulses is facilitated.
Why neostigmine is given with atropine in myasthenia gravis?
At the end of surgery, neostigmine has been given
for the reversal of neuromuscular blocking agents
with several adverse effects such as bradycardia
and profuse secretion.
Atropine has been used to prevent those side
effects of neostigmine.
Usage after surgery
The use of neostigmine significantly reduces the risk
that a patient will be left with muscle weakness in the
recovery room. Many anesthesiologists routinely use
neostigmine because postoperative muscle weakness
may lead to adverse events after surgery. Neostigmine
also relieves gastric contraction after surgery by
increasing the stimulation and tone of gastric muscles.
Atropine has been used to prevent those side effects of
neostigmine.
Neostigmine Neostigmine can induce generic ocular side effects
including: headache, brow pain, blurred vision,
phacodonesis, pericorneal injection, congestive iritis,
various allergic reactions, and rarely, retinal
detachment.
Neostigmine has a wide variety of side-effects such
as reduced heart rate (bradycardia), due to the
increase of acetylcholine at nerve terminals. For this
reason it is usually given along with an anti-
cholinergic drug such as atropine or glycopyrrolate.
Neostigmine
Gastrointestinal symptoms occur earliest after
ingestion and include anorexia, nausea, vomiting,
abdominal cramps, and diarrhea.
Side effects titles as review:
.
Nausea, headache, insomnia, dry mouth,
dizziness, vomiting, allergic reactions, skin rash,
hot flashes, joint pain, stroke, weakness, muscle
cramps, frequent urination
Pharmacokinetics of drug
Neostigmine is rapidly absorbed after intramuscular
injection (IM). Neostigmine binding to human serum
albumin is approximately 15 to 25%.
Neostigmine is metabolized in the liver by
microsomal enzymes. The apparent excretory half-
life of neostigmine is between 24 and 113 minutes.
Mohammad saleh Moallem
SHANDONG UNIVERSITY
默汉 201816230152

More Related Content

PPT
ANTICHOLINESTERASE DRUGS
PPTX
Reactive Arthritis
PPTX
Anaesthesia Vaporizers
PPTX
An introduction to medical ethics
PPTX
Vasodilators
PPTX
History and clinical examination in obstetrics
PPT
Regional Anesthesia
PPT
Bronchodilators
ANTICHOLINESTERASE DRUGS
Reactive Arthritis
Anaesthesia Vaporizers
An introduction to medical ethics
Vasodilators
History and clinical examination in obstetrics
Regional Anesthesia
Bronchodilators

What's hot (20)

PPT
Neuromuscular blocking agents
PPTX
Neuromuscular blocker
PPT
Suxamethonium
PPT
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
PPT
Muscle Relaxants
PPTX
Atracurium Vecuronium Pancuronium
PPTX
PPTX
Lidocain ppt
PPT
Muscle relaxant and reversal agents
PPTX
Inotropic agents
PPTX
General Anesthetics
PPTX
Adrenaline & Noradrenaline
PPTX
Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)
PPTX
Opioid receptors & opioid analgesics
PDF
Acetylcholine and succinylcholine
PPT
Ace inhibitor
PPTX
Antiarrhythmics
PPTX
Stage of anesthesia
PPTX
PPTX
Adrenaline(1)
Neuromuscular blocking agents
Neuromuscular blocker
Suxamethonium
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Muscle Relaxants
Atracurium Vecuronium Pancuronium
Lidocain ppt
Muscle relaxant and reversal agents
Inotropic agents
General Anesthetics
Adrenaline & Noradrenaline
Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)
Opioid receptors & opioid analgesics
Acetylcholine and succinylcholine
Ace inhibitor
Antiarrhythmics
Stage of anesthesia
Adrenaline(1)
Ad

Similar to Neostigmine - Mechanism of action, indications and side effects (20)

PPTX
Parasympathomimetics ( Cholinergic Agonists).pptx
PPTX
Myasthenia Gravis disease pharmacology ppt.pptx
PPTX
Myasthenia gravis
PPTX
Myasthenia Gravis
PPTX
anticholinesterases presentation by doctor
PPTX
MYASTHENIA GRAVIS.pptx
PDF
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
PDF
Neuromuscular blocking drugs_and_anticholinesterases_update_
PPTX
SKELETAL MUSCLE RELAXENT.pptx
PPTX
Myasthenia + gullian bare syn
PPTX
lec-3 Analgesics.pptx
PPTX
Pharmacology-Skeletal Muscle Relaxants.p
PDF
myasthenia graves &Lambert -Eaton myasthenc syndrome
PPTX
Session 3.Muscle and cholinesterrelaxantsase inhibitors.pptx
PPTX
Group-3-PHARMACOTHERAPY-OF-NEUROLOGIC-NERVOUS-SYSTEM-DISORDER-Copy.pptx
PDF
Pharmacology of neuromuscular_blocking_drugs_and_anticholinesterases_totw_026...
PPTX
final kavya kvdk pgy1pptt reversal.pptx
PPTX
N_Cholinomimetics_and_N_Cholinoblockers,_Anticholinesterases.pptx
PPTX
CHOLINERGIC NEUROTRANSMITTERS.pptx
PDF
Pharmacology Skeletal Muscle Relaxant.pdf
Parasympathomimetics ( Cholinergic Agonists).pptx
Myasthenia Gravis disease pharmacology ppt.pptx
Myasthenia gravis
Myasthenia Gravis
anticholinesterases presentation by doctor
MYASTHENIA GRAVIS.pptx
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
Neuromuscular blocking drugs_and_anticholinesterases_update_
SKELETAL MUSCLE RELAXENT.pptx
Myasthenia + gullian bare syn
lec-3 Analgesics.pptx
Pharmacology-Skeletal Muscle Relaxants.p
myasthenia graves &Lambert -Eaton myasthenc syndrome
Session 3.Muscle and cholinesterrelaxantsase inhibitors.pptx
Group-3-PHARMACOTHERAPY-OF-NEUROLOGIC-NERVOUS-SYSTEM-DISORDER-Copy.pptx
Pharmacology of neuromuscular_blocking_drugs_and_anticholinesterases_totw_026...
final kavya kvdk pgy1pptt reversal.pptx
N_Cholinomimetics_and_N_Cholinoblockers,_Anticholinesterases.pptx
CHOLINERGIC NEUROTRANSMITTERS.pptx
Pharmacology Skeletal Muscle Relaxant.pdf
Ad

More from Mohammad saleh Moallem (14)

PDF
Viral meningitis and Secondary epilepsy
PDF
Insulinoma - tumor of the beta cells of the islets of Langerhans
PDF
Basal ganglia and Parkinson's disease
PDF
Neurological Examination
PDF
Types of tumors and Neostigmine
PDF
Laparoscopic surgery and Right Adrenalectomy
PDF
Treatment of Nephrotic syndrome
PDF
Diagram of disease, PBL
PDF
Farmer lung's disease and COPD
PDF
Encephalitis, analyzing MRI and treatment of intractable epilepsy
PDF
Treatment option for mushroom poisoning
PDF
Medical Schema Chart of atherosclerosis
PDF
Facial nerve
PDF
Hemodialysis
Viral meningitis and Secondary epilepsy
Insulinoma - tumor of the beta cells of the islets of Langerhans
Basal ganglia and Parkinson's disease
Neurological Examination
Types of tumors and Neostigmine
Laparoscopic surgery and Right Adrenalectomy
Treatment of Nephrotic syndrome
Diagram of disease, PBL
Farmer lung's disease and COPD
Encephalitis, analyzing MRI and treatment of intractable epilepsy
Treatment option for mushroom poisoning
Medical Schema Chart of atherosclerosis
Facial nerve
Hemodialysis

Recently uploaded (20)

PPTX
Genetics and health: study of genes and their roles in inheritance
PPTX
This book is about some common childhood
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PPTX
presentation on dengue and its management
PPTX
presentation on causes and treatment of glomerular disorders
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PPTX
Approach to Abdominal trauma Gemme(COMMENT).pptx
PDF
495958952-Techno-Obstetric-sminiOSCE.pdf
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PPTX
Introduction to CDC (1).pptx for health science students
PPSX
Man & Medicine power point presentation for the first year MBBS students
PDF
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
PPTX
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
PPT
intrduction to nephrologDDDDDDDDDy lec1.ppt
PPTX
Peripheral Arterial Diseases PAD-WPS Office.pptx
DOCX
ORGAN SYSTEM DISORDERS Zoology Class Ass
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
PPTX
Applied anatomy and physiology of Esophagus .pptx
PPTX
Biostatistics Lecture Notes_Dadason.pptx
Genetics and health: study of genes and their roles in inheritance
This book is about some common childhood
periodontaldiseasesandtreatments-200626195738.pdf
presentation on dengue and its management
presentation on causes and treatment of glomerular disorders
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Approach to Abdominal trauma Gemme(COMMENT).pptx
495958952-Techno-Obstetric-sminiOSCE.pdf
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
ENT-DISORDERS ( ent for nursing ). (1).p
Introduction to CDC (1).pptx for health science students
Man & Medicine power point presentation for the first year MBBS students
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
intrduction to nephrologDDDDDDDDDy lec1.ppt
Peripheral Arterial Diseases PAD-WPS Office.pptx
ORGAN SYSTEM DISORDERS Zoology Class Ass
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
Applied anatomy and physiology of Esophagus .pptx
Biostatistics Lecture Notes_Dadason.pptx

Neostigmine - Mechanism of action, indications and side effects

  • 2.  What is the neostigmine? Please talk about its medical uses, mechanism of action and side effects. Question
  • 3. Neostigmine Neostigmine is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is also used in Anaesthesia to end the effects of non-depolarizing neuromuscular blocking medication. It is given by injection either into a vein, muscle, or under the skin. After injection effects are generally greatest within 30 minutes and last up to 4 hours.
  • 4. Indications of Neostigmine Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies destroy the communication between nerves and muscle, resulting in weakness of the skeletal muscles. Myasthenia gravis affects the voluntary muscles of the body, especially those that control the eyes, mouth, throat and limbs.
  • 5. Indications of Neostigmine Ogilvie syndrome is the acute dilatation of the colon in the absence of any mechanical obstruction in severely ill patients. Ogilvie syndrome may occur after surgery, especially following coronary artery bypass surgery and total joint replacement. Drugs that disturb colonic motility (such as anticholinergics or opioid analgesics) contribute to the development of this condition.
  • 6. Neostigmine Neostigmine is a cholinesterase inhibitor used in the symptomatic treatment of myasthenia gravis by improving muscle tone. Cholinesterase is a family of enzymes that catalyzes the hydrolysis of the neurotransmitter acetylcholine (ACh) into choline and acetic acid, a reaction necessary to allow a cholinergic neuron to return to its resting state after activation. So cholinesterase decrease the amount of Ach
  • 7. Description Acetylcholine is the chief neurotransmitter of the parasympathetic nervous system, the part of the autonomic nervous system (a branch of PNS) that contracts smooth muscles, dilates blood vessels, increases bodily secretions, and slows heart rate. In most people with myasthenia gravis, the immune system blocks or damages these acetylcholine receptors. The acetylcholine cannot then attach to the receptor and so the muscle is less able to contract.
  • 8. Description Cholinergic drugs stimulate the activation of the parasympathetic nervous system by activating receptors for acetylcholine. Anticholinergic drugs inhibit the parasympathetic nervous system by blocking the action of acetylcholine so that it cannot bind to receptors that initiate the parasympathetic response.
  • 9. Neostigmine Neostigmine is a cholinesterase inhibitor used in the symptomatic treatment of myasthenia gravis by improving muscle tone. Neostigmine is in the cholinergic family of medications. It works by blocking the action of acetylcholinesterase and therefore increases the levels of acetylcholine. Neostigmine: Cholinesterase inhibitor = ↑ ACh
  • 10. Neostigmine Neostigmine: Cholinesterase inhibitor = ↑ Ach Neostigmine works by slowing the breakdown of acetylcholine when it is released from nerve endings. This means that there is more acetylcholine available to attach to the muscle receptors and this improves the strength of your muscles. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier.
  • 11. Neostigmine Neostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. The drug inhibits acetylcholinesterase which is responsible for the degradation of acetylcholine. So, with acetylcholinesterase inhibited, more acetylcholine is present By interfering with the breakdown of acetylcholine, neostigmine indirectly stimulates both nicotinic and muscarinic receptors which are involved in muscle contraction. It does not cross the blood-brain barrier.
  • 12. How it acts as anticholinesterase? Neostigmine is an anticholinesterase inhibitor and inhibits the hydrolysis of acetylcholine by competing with acetylcholine for binding to acetylcholinesterase at the site of cholinergic transmission. By reducing the hydrolysis of acetylcholine, the transmission of nerve impulses is facilitated.
  • 13. Why neostigmine is given with atropine in myasthenia gravis? At the end of surgery, neostigmine has been given for the reversal of neuromuscular blocking agents with several adverse effects such as bradycardia and profuse secretion. Atropine has been used to prevent those side effects of neostigmine.
  • 14. Usage after surgery The use of neostigmine significantly reduces the risk that a patient will be left with muscle weakness in the recovery room. Many anesthesiologists routinely use neostigmine because postoperative muscle weakness may lead to adverse events after surgery. Neostigmine also relieves gastric contraction after surgery by increasing the stimulation and tone of gastric muscles. Atropine has been used to prevent those side effects of neostigmine.
  • 15. Neostigmine Neostigmine can induce generic ocular side effects including: headache, brow pain, blurred vision, phacodonesis, pericorneal injection, congestive iritis, various allergic reactions, and rarely, retinal detachment. Neostigmine has a wide variety of side-effects such as reduced heart rate (bradycardia), due to the increase of acetylcholine at nerve terminals. For this reason it is usually given along with an anti- cholinergic drug such as atropine or glycopyrrolate.
  • 16. Neostigmine Gastrointestinal symptoms occur earliest after ingestion and include anorexia, nausea, vomiting, abdominal cramps, and diarrhea. Side effects titles as review: . Nausea, headache, insomnia, dry mouth, dizziness, vomiting, allergic reactions, skin rash, hot flashes, joint pain, stroke, weakness, muscle cramps, frequent urination
  • 17. Pharmacokinetics of drug Neostigmine is rapidly absorbed after intramuscular injection (IM). Neostigmine binding to human serum albumin is approximately 15 to 25%. Neostigmine is metabolized in the liver by microsomal enzymes. The apparent excretory half- life of neostigmine is between 24 and 113 minutes.
  • 18. Mohammad saleh Moallem SHANDONG UNIVERSITY 默汉 201816230152